Literature DB >> 8088558

Age-related vision changes: a primary care guide.

T L Carter1.   

Abstract

Visual impairment becomes more prevalent with age. A person has "low vision" when legally blind or partially sighted. In addition, many older patients have functional visual impairment that affects their ability to read, even with corrective lenses. Normal visual changes that occur with aging include presbyopia, decreased contrast sensitivity, decreased dark/light adaptation, and delayed glare recovery. The four most prevalent age-related ocular diseases are macular degeneration, open-angle glaucoma, cataract, and diabetic retinopathy. The primary care practitioner can identify patients with visual problems with a careful history and in-office tests of visual acuity. Patients with visual impairments should be referred to an eye care practitioner for a more comprehensive ocular evaluation.

Entities:  

Mesh:

Year:  1994        PMID: 8088558

Source DB:  PubMed          Journal:  Geriatrics        ISSN: 0016-867X


  3 in total

1.  Safety, efficacy and refractive outcomes of LASIK surgery in patients aged 65 or older.

Authors:  Paloma López-Montemayor; Jorge E Valdez-García; Denise Loya-García; Julio C Hernandez-Camarena
Journal:  Int Ophthalmol       Date:  2017-06-23       Impact factor: 2.031

2.  Visual impairment and social isolation, depression and life satisfaction among older adults in Ghana: analysis of the WHO's Study on global AGEing and adult health (SAGE) Wave 2.

Authors:  John Tetteh; Gladys Fordjour; George Ekem-Ferguson; Anita Ohenewa Yawson; Vincent Boima; Kow Entsuah-Mensah; Richard Biritwum; Akye Essuman; George Mensah; Alfred Edwin Yawson
Journal:  BMJ Open Ophthalmol       Date:  2020-06-29

3.  N-Acetylcarnosine sustained drug delivery eye drops to control the signs of ageless vision: glare sensitivity, cataract amelioration and quality of vision currently available treatment for the challenging 50,000-patient population.

Authors:  Mark A Babizhayev; Leslie Burke; Philip Micans; Stuart P Richer
Journal:  Clin Interv Aging       Date:  2009-05-14       Impact factor: 4.458

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.